Published 2016
| Version v1
Publication
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer
Creators
- Buglione, Michela
- Maddalo, Marta
- CORVO', RENZO GIACINTO
- Pirtoli, Luigi
- Paiar, Fabiola
- Lastrucci, Luciana
- Stefanacci, Marco
- BELGIOIA, LILIANA
- Crociani, Monica
- Vecchio, Stefania
- Bonomo, Pierluigi
- Bertocci, Silvia
- Borghetti, Paolo
- Pasinetti, Nadia
- Triggiani, Luca
- Costa, Loredana
- Tonoli, Sandro
- Grisanti, Salvatore
- Magrini, Stefano Maria
Contributors
Others:
- Buglione, Michela
- Maddalo, Marta
- Corvo', RENZO GIACINTO
- Pirtoli, Luigi
- Paiar, Fabiola
- Lastrucci, Luciana
- Stefanacci, Marco
- Belgioia, Liliana
- Crociani, Monica
- Vecchio, Stefania
- Bonomo, Pierluigi
- Bertocci, Silvia
- Borghetti, Paolo
- Pasinetti, Nadia
- Triggiani, Luca
- Costa, Loredana
- Tonoli, Sandro
- Grisanti, Salvatore
- Magrini, Stefano Maria
Description
We report a subgroup analysis primarily focused on human papillomavirus (HPV)-related oropharyngeal cancer (OPC) from the Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer (CTXMAB+RT; ClinicalTrials.gov identifier NCT01216020) trial comparing radiation therapy with concomitant cisplatin (CDDP) versus concomitant cetuximab (CTX) as first-line treatment of locally advanced head and neck cancer.
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/859889
- URN
- urn:oai:iris.unige.it:11567/859889
Origin repository
- Origin repository
- UNIGE